Brian Daniels's most recent trade in Artiva Biotherapeutics Inc was a trade of 16,250 Director Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Sept. 10, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Artiva Biotherapeutics Inc | Brian Daniels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2026 | 16,250 | 16,250 | - | - | Director Stock Option (Right to Buy) | |
| Artiva Biotherapeutics Inc | Brian Daniels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2026 | 13,750 | 13,750 | - | - | Director Stock Option (Right to Buy) | |
| Artiva Biotherapeutics Inc | Brian Daniels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 13,750 | 13,750 | - | - | Director Stock Option (Right to Buy) |